Ginkgo Financial Statements From 2010 to 2026

DNA Stock  USD 6.91  0.14  1.99%   
Ginkgo Bioworks' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ginkgo Bioworks' valuation are provided below:
Gross Profit
123.2 M
Profit Margin
(1.84)
Market Capitalization
427.2 M
Enterprise Value Revenue
2.1493
Revenue
170.2 M
We have found one hundred twenty available fundamental trends for Ginkgo Bioworks Holdings, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Ginkgo Bioworks Holdings regular market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of March 4, 2026, Market Cap is expected to decline to about 437.8 M. In addition to that, Enterprise Value is expected to decline to about 675.2 M

Ginkgo Bioworks Total Revenue

246.88 Million

Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as Net Interest Income of 46.5 M, Interest Income of 23 M or Depreciation And Amortization of 48.5 M, as well as many indicators such as Price To Sales Ratio of 2.57, Dividend Yield of 0.0 or PTB Ratio of 0.86. Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.
  
Build AI portfolio with Ginkgo Stock
Check out the analysis of Ginkgo Bioworks Correlation against competitors.

Ginkgo Bioworks Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.6 B1.1 B1.1 B
Slightly volatile
Short and Long Term Debt Total255.2 M417.1 M119.7 M
Slightly volatile
Other Current Liabilities72.7 M66.5 M51.1 M
Slightly volatile
Total Current Liabilities123.8 M96 M74.9 M
Slightly volatile
Total Stockholder Equity483.2 M508.6 M672.9 M
Slightly volatile
Other Liabilities224.8 M249.3 M174.9 M
Slightly volatile
Net Tangible Assets1.1 B1.8 B845.7 M
Slightly volatile
Property Plant And Equipment Net404 M528.7 M208.4 M
Slightly volatile
Accounts Payable10.8 M10.6 MM
Slightly volatile
Cash158.8 M167.2 M590.1 M
Pretty Stable
Non Current Assets Total621.9 M647.9 M367.5 M
Slightly volatile
Non Currrent Assets Other50.4 M47.2 M26.8 M
Slightly volatile
Other Assets44.8 M47.3 M24.7 M
Slightly volatile
Cash And Short Term Investments648 M422.6 M633.9 M
Slightly volatile
Net Receivables37.5 M24 M25.6 M
Slightly volatile
Common Stock Shares Outstanding46 M55.5 M35.1 M
Slightly volatile
Liabilities And Stockholders Equity1.6 B1.1 B1.1 B
Slightly volatile
Non Current Liabilities Total433.7 M515.1 M270.1 M
Slightly volatile
Capital Surpluse4.3 B7.5 B2.5 B
Slightly volatile
Other Current Assets27.2 M25.2 M16.5 M
Slightly volatile
Other Stockholder Equity4.9 B6.7 B2.6 B
Slightly volatile
Total Liabilities557.5 M611.1 M345 M
Slightly volatile
Total Current Assets707.2 M471.8 M676.6 M
Slightly volatile
Cash And Equivalents962 M645.8 M665.5 M
Slightly volatile
Short Term Debt35 M33.3 M8.9 M
Slightly volatile
Intangible Assets55.3 M56.9 M26 M
Slightly volatile
Common Stock5.7 KK76 K
Slightly volatile
Property Plant Equipment374.2 M687.9 M216 M
Slightly volatile
Current Deferred Revenue27.7 M18.9 M30.8 M
Pretty Stable
Capital Lease Obligations564.8 M537.9 M143.3 M
Slightly volatile
Net Invested Capital1.2 B823.5 M715.7 M
Slightly volatile
Long Term Investments71.2 M43.6 M93.6 M
Slightly volatile
Property Plant And Equipment Gross518 M872.9 M311.6 M
Slightly volatile
Capital Stock4.3 K4.5 K116.6 K
Slightly volatile
Non Current Liabilities Other14.2 M14.9 M19 M
Slightly volatile
Net Working Capital728.3 M445.9 M544.7 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity49.6 M55.8 M60.9 M
Slightly volatile
Common Stock Total Equity193.1 K218.5 K171.4 K
Slightly volatile
Deferred Long Term Liabilities192.2 M201 M177.3 M
Slightly volatile

Ginkgo Bioworks Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income23 M44.4 M14.4 M
Slightly volatile
Depreciation And Amortization48.5 M59 M26.7 M
Slightly volatile
Interest Expense80.4 K84.6 K1.7 M
Slightly volatile
Selling General Administrative174.1 M183.3 M212.6 M
Slightly volatile
Total Revenue246.9 M170.2 M135.6 M
Slightly volatile
Gross Profit172.5 M138.6 M103.4 M
Slightly volatile
Other Operating Expenses461.2 M485.4 M538.2 M
Slightly volatile
Research Development231.6 M243.8 M282.7 M
Slightly volatile
Total Operating Expenses431.2 M453.9 M508.6 M
Slightly volatile
Reconciled Depreciation43.3 M72.5 M26.4 M
Slightly volatile
Non Operating Income Net Other70 M78.8 M86 M
Slightly volatile
Selling And Marketing Expenses76.8 M86.4 M94.3 M
Slightly volatile

Ginkgo Bioworks Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation77.5 M81.5 M238 M
Slightly volatile
Begin Period Cash Flow881.8 M567.4 M491.7 M
Slightly volatile
Depreciation45.5 M59 M25.4 M
Slightly volatile
Capital Expenditures7.3 M7.7 M29.8 M
Slightly volatile
End Period Cash Flow165.5 M174.2 M604 M
Pretty Stable
Change To Netincome2.2 B2.1 B712.2 M
Slightly volatile
Dividends Paid838.8 K882.9 K1.1 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.572.7084140
Slightly volatile
PTB Ratio0.860.906116.3516
Slightly volatile
Days Sales Outstanding79.8551.538261.9709
Pretty Stable
Book Value Per Share8.719.170819.5775
Very volatile
Stock Based Compensation To Revenue0.460.47920.6856
Slightly volatile
Capex To Depreciation0.120.12991.7538
Slightly volatile
PB Ratio0.860.906116.3516
Slightly volatile
EV To Sales3.974.177134
Slightly volatile
Inventory Turnover1.1 K1.1 K272
Slightly volatile
Days Of Inventory On Hand0.340.36141
Slightly volatile
Payables Turnover2.832.98323.6508
Slightly volatile
Sales General And Administrative To Revenue1.21.07720.9751
Slightly volatile
Research And Ddevelopement To Revenue2.411.43271.9849
Slightly volatile
Capex To Revenue0.04280.0450.3335
Slightly volatile
Cash Per Share7.247.620618.118
Very volatile
Days Payables Outstanding126122239
Slightly volatile
Income Quality0.50.54690.4128
Pretty Stable
Intangibles To Total Assets0.03280.05080.0231
Slightly volatile
Current Ratio8.874.916510.6035
Slightly volatile
Tangible Book Value Per Share7.748.144318.7747
Very volatile
Receivables Turnover5.667.08216.9856
Very volatile
Shareholders Equity Per Share8.719.170819.2707
Very volatile
Debt To Equity0.860.82010.1889
Slightly volatile
Capex Per Share0.130.13820.8728
Very volatile
Revenue Per Share4.333.06823.4797
Slightly volatile
Interest Debt Per Share3.97.52072.5999
Slightly volatile
Debt To Assets0.390.37250.1003
Slightly volatile
Operating Cycle48.9651.538273.9398
Pretty Stable
Price Book Value Ratio0.860.906116.3516
Slightly volatile
Days Of Payables Outstanding126122239
Slightly volatile
Ebt Per Ebit1.190.99471.4006
Slightly volatile
Company Equity Multiplier1.32.20161.4934
Slightly volatile
Long Term Debt To Capitalization0.360.410.4429
Slightly volatile
Total Debt To Capitalization0.470.45060.1229
Slightly volatile
Debt Equity Ratio0.860.82010.1889
Slightly volatile
Quick Ratio8.834.916510.5907
Slightly volatile
Net Income Per E B T1.10.99731.0033
Slightly volatile
Cash Ratio1.661.74229.5472
Slightly volatile
Days Of Inventory Outstanding0.340.36141
Slightly volatile
Days Of Sales Outstanding79.8551.538261.9709
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.381.04481.3876
Slightly volatile
Price To Book Ratio0.860.906116.3516
Slightly volatile
Fixed Asset Turnover0.310.32180.8047
Slightly volatile
Debt Ratio0.390.37250.1003
Slightly volatile
Price Sales Ratio2.572.7084140
Slightly volatile
Asset Turnover0.110.1520.1064
Slightly volatile
Gross Profit Margin0.580.81480.7605
Slightly volatile
Price Fair Value0.860.906116.3516
Slightly volatile

Ginkgo Bioworks Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap437.8 M460.9 M8.6 B
Slightly volatile
Enterprise Value675.2 M710.7 MB
Slightly volatile

Ginkgo Fundamental Market Drivers

Ginkgo Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ginkgo Bioworks Financial Statements

Ginkgo Bioworks stakeholders use historical fundamental indicators, such as Ginkgo Bioworks' revenue or net income, to determine how well the company is positioned to perform in the future. Although Ginkgo Bioworks investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ginkgo Bioworks' assets and liabilities are reflected in the revenues and expenses on Ginkgo Bioworks' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ginkgo Bioworks Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue18.9 M27.7 M
Total Revenue170.2 M246.9 M
Cost Of Revenue31.5 M29.9 M
Stock Based Compensation To Revenue 0.48  0.46 
Sales General And Administrative To Revenue 1.08  1.20 
Research And Ddevelopement To Revenue 1.43  2.41 
Capex To Revenue 0.05  0.04 
Revenue Per Share 3.07  4.33 
Ebit Per Revenue(1.85)(1.95)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
Check out the analysis of Ginkgo Bioworks Correlation against competitors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. Projected growth potential of Ginkgo fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ginkgo Bioworks assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(6.18)
Revenue Per Share
3.068
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.15)
Return On Equity
(0.51)
Understanding Ginkgo Bioworks Holdings requires distinguishing between market price and book value, where the latter reflects Ginkgo's accounting equity. The concept of intrinsic value - what Ginkgo Bioworks' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ginkgo Bioworks' price substantially above or below its fundamental value.
It's important to distinguish between Ginkgo Bioworks' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ginkgo Bioworks should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ginkgo Bioworks' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.